PMID: 8592112Feb 1, 1996Paper

Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions

Journal of Neurochemistry
A V AzaryanB M Cox

Abstract

The regulation of mu- (MOR) and delta-opioid receptor (DOR) after chronic cocaine administration has been studied. Male Sprague-Dawley rats were treated for 3 days with saline and cocaine (50 mg/kg/day) delivered by osmotic minipump. Expression of MOR and DOR mRNA in olfactory bulb, nucleus accumbens, and caudate-putamen (caudal and rostral parts) was estimated using quantitative competitive PCR assays after reverse transcription. No changes in the levels of mRNA for DOR were detected after exposure to cocaine in the brain regions examined. A significant increase in the level of MOR mRNA was detected in nucleus accumbens after 3 days of cocaine treatment. In caudate-putamen and olfactory bulb, no change in MOR mRNA was observed after cocaine administration. Both SCH 23390 and eticlopride, selective antagonists of D1- and D2-dopamine receptors, respectively, blocked this cocaine-induced up-regulation of MOR mRNA in nucleus accumbens. We suggest that endogenous opioid systems in nucleus accumbens, the brain region specifically associated with the reinforcing properties of addictive drugs, are regulated by dopaminergic mechanisms and influenced by cocaine treatment.

Citations

Oct 9, 1998·The Journal of Biological Chemistry·J L KoH H Loh
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·P Y LawH H Loh
Jun 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Almudena López-FandoJavier Garzón
Jul 19, 2001·Annals of the New York Academy of Sciences·E M Unterwald
Oct 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francesco LeriMary Jeanne Kreek
Nov 10, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Cheol Kyu HwangHorace H Loh
May 20, 2015·British Journal of Pharmacology·Florence NobleNicolas Marie
Mar 20, 2002·Molecular Pharmacology·Christine BörnerJürgen Kraus
Feb 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francesco LeriJane Stewart
Oct 1, 2009·Physiological Reviews·Julie Le MerrerBrigitte L Kieffer
Apr 4, 2021·The European Journal of Neuroscience·David De Sa NogueiraKatia Befort
Jun 25, 1999·Brain Research. Molecular Brain Research·M L Andria, E J Simon
Aug 26, 1998·Drug and Alcohol Dependence·M J Kreek, G F Koob
Feb 5, 1998·European Journal of Pharmacology·F SehbaB C Yoburn
Jul 10, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shani GendelisYonatan M Kupchik
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.